Alex Mabou Tagne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alex Mabou Tagne has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Daniele Piomelli
Department of Anatomy and Neurobiology, University of California, Irvine, USA
4 shared publications - Heidi C. Avalos
Department of Anatomy and Neurobiology, University of California, Irvine
2 shared publications - Hye-Lim Lee
Department of Anatomy and Neurobiology, University of California, Irvine
2 shared publications - Jean Katz
Department of Anatomy and Neurobiology, University of California, Irvine
2 shared publications - Kwang-Mook Jung
University of California, Irvine
2 shared publications Dominick D’AGosta
Department of Anatomy and Neurobiology, University of California, Irvine
1 shared publication
Latest Publications
- 1 August 2025
- Published by MyJove Corporation
- No. 222,p. e68358
JoVE Video Dataset
Δ9-tetrahydrocannabinol (THC) is responsible for the intoxicating (psychotropic) effects of cannabis and cannabis-derived products currently available in the legal and illegal markets. The psychotropic effects of THC are produced via activation of CB1 cannabinoid receptors in the brain, which are normally engaged by endogenous cannabinoid (endocannabinoid) substances. Outside the brain, THC contributes to the regulation of a wide range of physiological processes by activating CB1 and CB2 receptors. The physiological functions served by endocannabinoid substances and cannabinoid receptors - collectively known as the endocannabinoid system - change considerably throughout the lifespan, with adolescence being a period of heightened sensitivity to the contributions of this signaling complex. This article describes a protocol for preparing THC for parenteral administration and assessing its acute pharmacodynamic effects in mice of both sexes at two developmental stages: adolescence and young adulthood. Focusing on three doses that are widely used in the literature (1, 5, and 10 mg/kg) and the intraperitoneal route, the well-known effects of THC-catalepsy induction, locomotor activity inhibition, and nociception suppression-are illustrated. Moreover, given THC's status as a controlled substance in the United States, the procedures for obtaining and storing it in compliance with current legislation are briefly outlined.
- 1 August 2025
- Published by MyJove Corporation
- No. 222,p. e68358
JoVE Video Dataset
Δ9-tetrahydrocannabinol (THC) is responsible for the intoxicating (psychotropic) effects of cannabis and cannabis-derived products currently available in the legal and illegal markets. The psychotropic effects of THC are produced via activation of CB1 cannabinoid receptors in the brain, which are normally engaged by endogenous cannabinoid (endocannabinoid) substances. Outside the brain, THC contributes to the regulation of a wide range of physiological processes by activating CB1 and CB2 receptors. The physiological functions served by endocannabinoid substances and cannabinoid receptors - collectively known as the endocannabinoid system - change considerably throughout the lifespan, with adolescence being a period of heightened sensitivity to the contributions of this signaling complex. This article describes a protocol for preparing THC for parenteral administration and assessing its acute pharmacodynamic effects in mice of both sexes at two developmental stages: adolescence and young adulthood. Focusing on three doses that are widely used in the literature (1, 5, and 10 mg/kg) and the intraperitoneal route, the well-known effects of THC-catalepsy induction, locomotor activity inhibition, and nociception suppression-are illustrated. Moreover, given THC's status as a controlled substance in the United States, the procedures for obtaining and storing it in compliance with current legislation are briefly outlined.
- 1 August 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 222,p. e68358
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Δ9-tetrahydrocannabinol (THC) is responsible for the intoxicating (psychotropic) effects of cannabis and cannabis-derived products currently available in the legal and illegal markets. The psychotropic effects of THC are produced via activation of CB1 cannabinoid receptors in the brain, which are normally engaged by endogenous cannabinoid (endocannabinoid) substances. Outside the brain, THC contributes to the regulation of a wide range of physiological processes by activating CB1 and CB2 receptors. The physiological functions served by endocannabinoid substances and cannabinoid receptors - collectively known as the endocannabinoid system - change considerably throughout the lifespan, with adolescence being a period of heightened sensitivity to the contributions of this signaling complex. This article describes a protocol for preparing THC for parenteral administration and assessing its acute pharmacodynamic effects in mice of both sexes at two developmental stages: adolescence and young adulthood. Focusing on three doses that are widely used in the literature (1, 5, and 10 mg/kg) and the intraperitoneal route, the well-known effects of THC-catalepsy induction, locomotor activity inhibition, and nociception suppression-are illustrated. Moreover, given THC's status as a controlled substance in the United States, the procedures for obtaining and storing it in compliance with current legislation are briefly outlined.
- 1 August 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 222,p. e68358
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Δ9-tetrahydrocannabinol (THC) is responsible for the intoxicating (psychotropic) effects of cannabis and cannabis-derived products currently available in the legal and illegal markets. The psychotropic effects of THC are produced via activation of CB1 cannabinoid receptors in the brain, which are normally engaged by endogenous cannabinoid (endocannabinoid) substances. Outside the brain, THC contributes to the regulation of a wide range of physiological processes by activating CB1 and CB2 receptors. The physiological functions served by endocannabinoid substances and cannabinoid receptors - collectively known as the endocannabinoid system - change considerably throughout the lifespan, with adolescence being a period of heightened sensitivity to the contributions of this signaling complex. This article describes a protocol for preparing THC for parenteral administration and assessing its acute pharmacodynamic effects in mice of both sexes at two developmental stages: adolescence and young adulthood. Focusing on three doses that are widely used in the literature (1, 5, and 10 mg/kg) and the intraperitoneal route, the well-known effects of THC-catalepsy induction, locomotor activity inhibition, and nociception suppression-are illustrated. Moreover, given THC's status as a controlled substance in the United States, the procedures for obtaining and storing it in compliance with current legislation are briefly outlined.
- 4 August 2022
- Published by Elsevier in Experimental Neurology
- Vol. 357, 114194
Synergistic antinociceptive effects of concomitant NAAA and peripheral FAAH inhibition
- 4 August 2022
- Published by Elsevier in Experimental Neurology
- Vol. 357, 114194
Synergistic antinociceptive effects of concomitant NAAA and peripheral FAAH inhibition
- 1 December 2021
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 53, 19-24
Frequent Δ9- tetrahydrocannabinol exposure during adolescence impairs sociability in adult mice exposed to an aversive painful stimulus
- 1 December 2021
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 53, 19-24
Frequent Δ9- tetrahydrocannabinol exposure during adolescence impairs sociability in adult mice exposed to an aversive painful stimulus